BIIB and AMGN Related Headlines
Go Back
-
May 1, 2013 07:20AM
Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List
-
May 1, 2013 06:45AM
Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy
-
Sep 10, 2012 12:55PM
UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)
BIIB and AMGN Related Press Releases
Go Back
-
Jun 10, 2013 05:00AM
RBCC Explores New Funding for Expansion
-
Jun 5, 2013 05:00AM
RBCC Poised To Gain Share Of $142 Billion Market
-
May 30, 2013 05:00AM
RBCC to Drive Growth Through Personalized Medicine
-
May 21, 2013 05:00AM
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
-
May 13, 2013 05:00AM
RBCC Partner n3D Signs U.S. Distribution Agreement
-
May 6, 2013 05:00AM
World’s Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D
-
Apr 30, 2013 05:00AM
RBCC: Personalized Medicine Poised to Revolutionize Insurance & Pharmaceuticals
-
Apr 24, 2013 05:00AM
RBCC Looks Overseas for Potentially Lucrative Licensing Opportunities
BIIB and AMGN Related SEC Filings
Go Back